Patent Assignment
Reel/Frame 013691/0930
Assignment of Assignor's Interest
Recorded: 2003-01-24
Pages: 4
Assignor
PANGENE CORPORATION
Executed: 2002-12-31
Assignee
NAPRO BIO THERAPEUTICS, INC.
6304 SPINE ROAD, UNIT A, BOULDER, COLORADO, 80301
Covered Properties
(2)
Recombinase Mediated Dna Therapies
Patent:
5,929,043 →
Application:
08/882,756 →
Recombinase Mediated Dna Modifications
Patent:
6,245,565 →
Application:
09/301,153 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 11, 2000
From: DAYN, ANDREW (A.K.A. ANDREY DAYN)
To: PANGENE CORPORATION
Reel/Frame 011356/0107 →
Assignment of Assignor's Interest
Sep 28, 2004
From: NAPRO BIO THERAPEUTICS, INC.
To: TAPESTRY PHARMACEUTICALS, INC.
Reel/Frame 015190/0282 →
Assignment of Assignor's Interest
Jun 7, 2005
From: TAPESTRY PHARMACEUTICALS, INC.
To: INVITROGEN CORPORATION
Reel/Frame 016097/0614 →
Security Agreement
Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →
Merger
Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
Lien Release
Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
Corrective Assignment to Correct the Application No 09452626 Previously Recorded on Reel 023882 Frame 0551. Assignor(S) Hereby Confirms the Merger Should Not Have Been Recorded Against This Patent Application Number.
Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →